Abstract Details

Title Persistent Neuropsychiatric Symptoms Predict Worse Cognitive and Functional Outcome in Alzheimer[apos]s Disease

Topic Behavioral Neurology

Presentation(s) (-)

Poster/Presentation
Number 007

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Stephane Poulin, MD (Centre Hospitalier Universitaire De Quebec)	No disclosure on file
Bradford Dickerson, MD, FAAN	Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axovant. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave LifeSciences. Dr. Dickerson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arkuda. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Dickerson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Dickerson has received publishing royalties from a publication relating to health care. Dr. Dickerson has received publishing royalties from a publication relating to health care.
Keren Regev, MD	Dr. Regev has nothing to disclose.
	No disclosure on file